apovincaminic acid

structure in first source

Networked: 14 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- Alkaloids: 5398
  - Indole Alkaloids: 200
    - Secologanin Tryptamine Alkaloids: 81
      - Vinca Alkaloids: 463
        apovincaminic acid: 14
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Indoles: 200
      - Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        apovincaminic acid: 14
    - Indolizines: 3
      - Indolizidines: 2
        Indole Alkaloids: 200
        Secologanin Tryptamine Alkaloids: 81
        Vinca Alkaloids: 463
        apovincaminic acid: 14

Experts

1.	Ermakova, G A: 1 article (09/2006)
2.	Makarova, L M: 1 article (09/2006)
3.	Pogorelyĭ, V E: 1 article (09/2006)
4.	Prikhod'ko, M A: 1 article (09/2006)
5.	Sernov, L H: 1 article (09/2006)
6.	Skachilova, S Ia: 1 article (09/2006)
7.	Dézsi, László: 1 article (01/2002)
8.	Kis-Varga, Istvánné: 1 article (01/2002)
9.	Komlódi, Zsolt: 1 article (01/2002)
10.	Kárpáti, Egon: 1 article (01/2002)

Related Diseases

1.	Hypoxia (Hypoxemia) 10/01/1994 - "The cerebral protective effects of VA-045, a novel apovincaminic acid derivative, were investigated in mice under conditions of normobaric hypoxia, histotoxic anoxia by potassium cyanide (KCN), and complete ischemia. " 01/01/1996 - "Effects of VA-045, a novel apovincaminic acid derivative, on neuronal damage induced by hypoxia or by excitatory amino acids (glutamate (Glu), N-methyl-D-aspartate and kainate) were examined in cultures of the rat cortices. "
2.	Ischemia 10/01/1994 - "The cerebral protective effects of VA-045, a novel apovincaminic acid derivative, were investigated in mice under conditions of normobaric hypoxia, histotoxic anoxia by potassium cyanide (KCN), and complete ischemia. "
3.	Renal Insufficiency (Renal Failure) 04/01/1984 - "Effects of renal insufficiency on the pharmacokinetics of vinpocetine and its main metabolite, apovincaminic acid (AVA) were investigated in the present study. "
4.	Stroke (Strokes) 01/01/2002 - "The aim of the present study was to review neuroprotective therapy from the preclinical point of view as a potential tool for the treatment of stroke, as well as to discuss neuroprotective effects of the apovincaminic acid derivative vinpocetine (Cavinton). "
5.	Memory Disorders (Memory Loss) 09/01/1997 - "In the present study, we examined the effects of (+)-eburnamenine-14-carboxylic acid (2-nitroxyethyl) ester (VA-045), a novel derivative of apovincaminic acid, on learning and memory deficits associated with a mild traumatic brain injury (TBI) in mice. "

Related Drugs and Biologics

1.	2-(nitrooxy)ethyl apovincaminate
2.	Potassium Cyanide
3.	vinpocetine
4.	Esters
5.	Carboxylic Acids
6.	Neuroprotective Agents
7.	Excitatory Amino Acids
8.	Glutamic Acid (Glutamate)
9.	N-Methylaspartate (NMDA)
10.	Kainic Acid (Kainate)

Related Therapies and Procedures

1.	Therapeutics